查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2084892

人工智慧在糖尿病管理領域的市場：按設備類型、技術、組件、部署模式和最終用戶分類－2026-2032年全球市場預測

Artificial Intelligence in Diabetes Management Market by Device Type, Technology, Component, Deployment Mode, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，糖尿病管理人工智慧 (AI) 市場規模將成長至 90.4 億美元，複合年成長率為 31.66%。

主要市場統計數據
基準年 2025 13.1億美元
預計年份：2026年 17.2億美元
預測年份 2032 90.4億美元
複合年成長率 (%) 31.66%

隨著醫療系統面臨糖尿病患者數量不斷成長、醫護人員短缺以及對持續個人化支援的需求日益增加等挑戰，人工智慧在糖尿病管理領域的應用正從先導計畫走向實際的醫療基礎設施。根據國際糖尿病聯盟（IDF）估計，2021年全球有5.37億成年人患有糖尿病，預計到2030年這一數字將達到6.43億，到2045年將達到7.83億。這導致對人工智慧驅動的血糖值監測、預測分析、胰島素劑量調整輔助以及遠端患者管理等方面的需求持續成長。

對於醫療服務提供者和保險公司而言，最有價值的提案是可衡量的風險分層、治療順從性、早期療育和工作流程效率的提升。整合電子健康記錄、持續血糖監測數據、理賠數據、實驗室結果和行為訊號的人工智慧工具，有助於改善人群健康管理，同時支持早期發現低血糖風險、糖尿病併發症和護理缺口。

將重塑糖尿病照護的變革性變化

連網型設備、雲端分析、監管現代化以及持續血糖監測的廣泛應用正在改變糖尿病護理的格局。美國糖尿病協會 (ADA) 的護理標準日益強調糖尿病相關技術的作用，包括持續血糖監測和自動胰島素輸注，而監管機構也在不斷完善對醫療設備軟體、臨床決策支援、網路安全和自適應演算法的要求。

人工智慧的累積影響

當演算法被整合到糖尿病護理的整個流程中時，人工智慧的累積影響最為顯著，這些流程包括篩檢、診斷支援、治療最佳化、併發症檢測、藥物依從性管理和療效監測。有實證依據的應用案例包括糖尿病視網膜病變篩檢、低血糖預測警報、胰島素劑量支持、高風險患者的自動分診以及腎臟、心血管和足部併發症的風險預測。

關鍵區域洞察

亞太地區可望在人工智慧應用於糖尿病管理方面發揮核心作用。這是因為中國和印度的糖尿病患者數量龐大，而日本、澳洲和韓國則擁有成熟的數位健康生態系統、廣泛的連網設備普及以及先進的臨床基礎設施。在全部區域，第2型糖尿病盛行率的上升、都市化進程的加快、智慧型手機的普及以及政府對數位健康的日益重視，都在推動人工智慧血糖值分析、遠端患者監護和併發症篩檢等技術的應用。

關鍵的群體特定見解

儘管東南亞國協透過行動醫療平台、都市區糖尿病診所、擴大保險覆蓋範圍以及公私合營開展數位醫療計畫取得了進展，但各成員國的保險報銷體系成熟度和專科醫生服務可及性差異顯著。在海灣合作理事會（GCC）國家，人工智慧驅動的醫療保健作為國家轉型計劃的一部分，正得到大量投資，而由於高肥胖率、久坐的生活方式以及2型糖尿病負擔日益加重等風險因素，糖尿病管理已成為優先事項。

主要國家的概況

美國疾病管制與預防中心報告稱，該國糖尿病患病人數達3840萬，且持續血糖監測、遠端醫療、遠端患者監護以及經監管機構批准的軟體工具的應用日益普及，使其成為創新和保險報銷的重要市場。加拿大致力於實現慢性病照護的公平取得、公共衛生協調以及引入虛擬醫療服務，而墨西哥則在2型糖尿病負擔沉重的背景下，透過公共計畫和私人醫療服務網路擴大糖尿病管理。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的人工智慧模型、可衡量的結果以及工作流程整合，而非獨立的數位功能。最具吸引力的策略是將持續血糖監測數據、電子健康記錄、行為指導、藥物管理、胰島素給藥支持和併發症篩檢整合到一個可互通的糖尿病管理平台。

調查方法

本執行摘要基於可靠來源的二手研究，包括國際糖尿病聯盟 (IDF)、世界衛生組織 (WHO)、美國疾病管制與預防中心 (CDC)、美國糖尿病協會 (ADA)、美國食品資訊來源食品藥物管理局(FDA) 的指導意見、歐洲法規結構、同行評審的臨床文獻、國家數位健康戰略和公共衛生政策文件。

結論

隨著醫療系統追求早期療育、個人化治療和可擴展的慢性病支持，人工智慧正成為下一代糖尿病管理的核心驅動力。這一趨勢的促進因素包括糖尿病盛行率的上升、持續血糖監測的廣泛應用、數位醫療基礎設施的成熟、監管指導的加強以及人們對軟體驅動型醫療保健日益成長的接受度。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：糖尿病管理中的人工智慧市場：按設備類型分類

  • 血糖值儀
    • 無創血糖儀
    • SMBG
  • 閉合迴路系統
    • 完全封閉回路型
    • 混合閉合迴路
  • 持續血糖監測
    • 間歇掃描式動態血糖監測
    • 即時動態血糖監測
  • 胰島素幫浦
    • 貼片幫浦
    • 管式幫浦

第8章：糖尿病管理領域的人工智慧市場：按技術分類

  • 決策支援系統
    • 警報生成
    • 建議劑量
  • 機器學習
  • 行動應用
  • 預測分析
    • 預測血糖值的變化趨勢
    • 風險預測

第9章：糖尿病管理領域的人工智慧市場：按組件分類

  • 硬體
    • 泵浦
    • 感應器
    • 穿戴式裝置
  • 軟體
    • 演算法
    • 資料管理
    • 使用者介面

第10章：人工智慧在糖尿病管理領域的市場：依部署模式分類

  • 基於雲端的
    • 混合雲端
    • 公共雲端
  • 現場
    • 邊緣運算
    • 基於伺服器的

第11章：糖尿病管理中的人工智慧市場：按最終用戶分類

  • 診所
    • 糖尿病中心
    • 一般診所
  • 居家照護
    • 遠端監控
    • 自我監測
  • 醫院
    • 住院治療
    • 門診
  • 研究機構
    • 學術機構
    • 私人的

第12章：糖尿病管理領域的人工智慧市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：糖尿病管理領域的人工智慧市場：按群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：糖尿病管理領域的人工智慧市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Apple Inc.
  • Bigfoot Biomedical, Inc.
  • Dexcom, Inc.
  • Diabeloop SA
  • Eyenuk, Inc.
  • F. Hoffmann-La Roche Ltd
  • Glooko Inc.
  • Google LLC by Alphabet Inc.
  • Insulet Corporation
  • International Business Machines Corporation
  • Livongo Health, Inc.
  • Medtronic plc
  • Omada Health, Inc.
  • Tandem Diabetes Care, Inc.
  • Teladoc Health, Inc.
  • Tidepool Inc.
  • Virta Health Corp.
  • Wellthy Therapeutics Pvt. Ltd.
Product Code: MRR-4369010656EF

The Artificial Intelligence in Diabetes Management Market is projected to grow by USD 9.04 billion at a CAGR of 31.66% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.31 billion
Estimated Year [2026] USD 1.72 billion
Forecast Year [2032] USD 9.04 billion
CAGR (%) 31.66%

Artificial intelligence in diabetes management is moving from pilot projects to operational care infrastructure as health systems confront rising prevalence, clinician shortages, and the need for continuous, personalized support. The International Diabetes Federation estimated that 537 million adults lived with diabetes in 2021, with the total projected to reach 643 million by 2030 and 783 million by 2045, creating sustained demand for AI-enabled glucose monitoring, predictive analytics, insulin titration support, and remote patient management.

For providers and payers, the strongest value proposition is measurable improvement in risk stratification, adherence, early intervention, and workflow efficiency. AI tools that integrate electronic health records, continuous glucose monitoring data, claims, laboratory results, and behavioral signals can support earlier detection of hypoglycemia risk, diabetes complications, and care gaps while improving population health management.

Transformative Shifts Reshaping Diabetes Care

The landscape is being reshaped by connected devices, cloud-based analytics, regulatory modernization, and wider adoption of continuous glucose monitoring. The American Diabetes Association's Standards of Care increasingly recognize the role of diabetes technology, including continuous glucose monitoring and automated insulin delivery, while regulators are refining expectations for software as a medical device, clinical decision support, cybersecurity, and adaptive algorithms.

A major shift is the transition from episodic clinic-based diabetes care to continuous, data-driven care. AI-powered decision support can identify patients who need medication review, nutrition coaching, retinal screening, nephropathy testing, cardiovascular risk assessment, or behavioral support, enabling organizations to move from reactive treatment to proactive chronic disease management.

Cumulative Impact of Artificial Intelligence

The cumulative impact of artificial intelligence is strongest when algorithms are embedded across the full diabetes journey: screening, diagnosis support, therapy optimization, complication detection, adherence management, and outcomes monitoring. Evidence-backed use cases include diabetic retinopathy screening, predictive hypoglycemia alerts, insulin dosing assistance, automated triage of high-risk patients, and risk prediction for kidney, cardiovascular, and foot complications.

At scale, AI can support reductions in avoidable emergency visits, improve time-in-range for insulin users, and strengthen value-based care programs by identifying actionable risk earlier. However, impact depends on validated datasets, transparent performance monitoring, cybersecurity, clinician oversight, regulatory compliance, and equitable access for underserved populations that carry a disproportionate diabetes burden.

Key Regional Insights

Asia-Pacific is central to AI in diabetes management because China and India account for very large diabetes populations, while Japan, Australia, and South Korea have mature digital health ecosystems, connected device adoption, and advanced clinical infrastructure. Across the region, rising type 2 diabetes prevalence, urbanization, smartphone penetration, and government interest in digital health are supporting the use of AI-enabled glucose analytics, remote patient monitoring, and complication screening.

North America remains a leading commercialization environment through advanced reimbursement structures, high continuous glucose monitoring adoption, strong clinical research networks, telehealth normalization, and regulatory pathways for software-enabled diabetes technologies. Europe benefits from national diabetes programs, interoperable health data initiatives, the European Health Data Space agenda, and the EU AI Act's risk-based governance approach, creating strong demand for trustworthy, clinically validated, and privacy-compliant AI solutions.

Latin America is expanding remote monitoring through private provider networks, public health digitization, and growing attention to chronic disease management in countries with rising obesity and diabetes burdens. The Middle East is prioritizing diabetes prevention and digital care in national health strategies, particularly across Gulf economies where type 2 diabetes prevalence is a major public health concern. Africa remains underpenetrated but offers long-term opportunity through mobile-first screening, community health programs, low-cost AI triage, and diabetic retinopathy detection models suited to resource-constrained settings.

Key Group Insights

ASEAN markets are progressing through mobile health platforms, urban diabetes clinics, expanding insurance coverage, and public-private digital health collaborations, although reimbursement maturity and specialist access vary widely across member states. GCC countries are investing heavily in AI-enabled healthcare as part of national transformation plans, with diabetes management a priority because of high obesity rates, sedentary lifestyle risk factors, and the growing burden of type 2 diabetes.

The European Union is emphasizing trustworthy AI, interoperability, privacy protection, clinical evidence, and post-market monitoring, making compliance a core requirement for AI diabetes management solutions. BRICS countries combine large patient populations with expanding digital infrastructure, creating scale opportunities for AI-enabled screening, remote monitoring, and population health management, while also requiring localized datasets, affordability, and integration with public health systems.

G7 markets provide strong evidence-generation, regulatory clarity, clinical adoption, and reimbursement pathways for AI in diabetes care, particularly where continuous glucose monitoring, electronic health records, and digital therapeutics are already embedded in care models. NATO countries increasingly view health data security, cyber resilience, and supply-chain assurance as strategic requirements, which raises expectations for secure AI deployment, protected patient data exchange, and resilient connected diabetes technologies.

Key Country Insights

The United States is a major innovation and reimbursement market, supported by CDC-reported diabetes prevalence of 38.4 million people and strong adoption of continuous glucose monitoring, telehealth, remote patient monitoring, and regulator-cleared software tools. Canada emphasizes equitable chronic care access, public health coordination, and virtual care adoption, while Mexico is expanding diabetes management through public programs and private provider networks amid a high national burden of type 2 diabetes.

Brazil is advancing digital health and diabetes care through a combination of public health initiatives, private healthcare networks, and growing use of telemedicine. The United Kingdom is strengthening digital diabetes prevention, remote monitoring, and technology-enabled care within a national health system model, while Germany benefits from structured disease management programs, digital health reimbursement mechanisms, and strong medical technology adoption. France is advancing remote monitoring reimbursement and chronic care digitization, Italy and Spain are using regional health systems to expand diabetes technology access, and Russia remains influenced by healthcare localization, procurement requirements, and infrastructure differences across regions.

China offers major scale for AI in diabetes management through large patient volumes, hospital digitization, and rapid adoption of mobile health tools, while India's opportunity is driven by one of the world's largest diabetes populations, expanding smartphone use, and growing demand for low-cost screening and coaching. Japan combines aging-population needs with advanced device integration and clinical infrastructure, Australia supports evidence-led digital health adoption through national digital health capabilities, and South Korea leads in connected health infrastructure, broadband penetration, and technology-enabled chronic disease management.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated AI models, measurable outcomes, and workflow integration over standalone digital features. The most defensible strategies combine continuous glucose monitoring data, electronic health record integration, behavioral coaching, medication intelligence, insulin dosing support, and complication screening into interoperable diabetes management platforms.

Organizations should invest in regulatory readiness, real-world evidence, cybersecurity, bias testing, model monitoring, and explainable AI. Commercial teams should align product claims with payer and provider priorities such as fewer acute events, improved HbA1c control, better time-in-range, higher screening adherence, and lower total cost of care. Partnerships with providers, pharmacies, employers, public health agencies, and device manufacturers can accelerate adoption while improving access and continuity of care.

Research Methodology

This executive summary is informed by secondary research from recognized sources including the International Diabetes Federation, World Health Organization, U.S. CDC, American Diabetes Association, U.S. FDA guidance, European regulatory frameworks, peer-reviewed clinical literature, national digital health strategies, and public health policy documents.

The methodology emphasizes triangulation across epidemiology, regulatory developments, technology adoption, reimbursement signals, clinical evidence, and healthcare digitization. Insights were assessed for relevance to AI in diabetes management, including continuous glucose monitoring analytics, automated insulin delivery support, clinical decision support, diabetic retinopathy screening, remote patient monitoring, predictive risk stratification, and AI-enabled population health management.

Conclusion

Artificial intelligence is becoming a core enabler of next-generation diabetes management as healthcare systems seek earlier intervention, personalized therapy, and scalable chronic disease support. Momentum is reinforced by rising diabetes prevalence, expanding continuous glucose monitoring adoption, maturing digital health infrastructure, stronger regulatory guidance, and growing acceptance of software-enabled medical care.

The strongest performers will be organizations that prove clinical value, protect patient data, meet regulatory expectations, integrate into care workflows, and deliver equitable outcomes across diverse populations. AI will not replace clinicians, but it will increasingly augment diabetes care teams with predictive insights, automation, continuous patient engagement, and more targeted chronic disease interventions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Artificial Intelligence in Diabetes Management Market, by Device Type

  • 7.1. Blood Glucose Meter
    • 7.1.1. Non Invasive Bg Meter
    • 7.1.2. Smbg
  • 7.2. Closed Loop System
    • 7.2.1. Fully Closed Loop
    • 7.2.2. Hybrid Closed Loop
  • 7.3. Continuous Glucose Monitor
    • 7.3.1. Intermittently Scanned Cgm
    • 7.3.2. Real Time Cgm
  • 7.4. Insulin Pump
    • 7.4.1. Patch Pump
    • 7.4.2. Tubed Pump

8. Artificial Intelligence in Diabetes Management Market, by Technology

  • 8.1. Decision Support Systems
    • 8.1.1. Alert Generation
    • 8.1.2. Dose Recommendation
  • 8.2. Machine Learning
  • 8.3. Mobile Applications
  • 8.4. Predictive Analytics
    • 8.4.1. Glucose Trend Prediction
    • 8.4.2. Risk Prediction

9. Artificial Intelligence in Diabetes Management Market, by Component

  • 9.1. Hardware
    • 9.1.1. Pumps
    • 9.1.2. Sensors
    • 9.1.3. Wearable Devices
  • 9.2. Software
    • 9.2.1. Algorithms
    • 9.2.2. Data Management
    • 9.2.3. User Interface

10. Artificial Intelligence in Diabetes Management Market, by Deployment Mode

  • 10.1. Cloud Based
    • 10.1.1. Hybrid Cloud
    • 10.1.2. Public Cloud
  • 10.2. On Premise
    • 10.2.1. Edge Computing
    • 10.2.2. Server Based

11. Artificial Intelligence in Diabetes Management Market, by End User

  • 11.1. Clinic
    • 11.1.1. Diabetes Center
    • 11.1.2. General Clinic
  • 11.2. Home Care
    • 11.2.1. Remote Monitoring
    • 11.2.2. Self Monitoring
  • 11.3. Hospital
    • 11.3.1. Inpatient
    • 11.3.2. Outpatient
  • 11.4. Research Institute
    • 11.4.1. Academic
    • 11.4.2. Private

12. Artificial Intelligence in Diabetes Management Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Artificial Intelligence in Diabetes Management Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Artificial Intelligence in Diabetes Management Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Apple Inc.
  • 16.3. Bigfoot Biomedical, Inc.
  • 16.4. Dexcom, Inc.
  • 16.5. Diabeloop SA
  • 16.6. Eyenuk, Inc.
  • 16.7. F. Hoffmann-La Roche Ltd
  • 16.8. Glooko Inc.
  • 16.9. Google LLC by Alphabet Inc.
  • 16.10. Insulet Corporation
  • 16.11. International Business Machines Corporation
  • 16.12. Livongo Health, Inc.
  • 16.13. Medtronic plc
  • 16.14. Omada Health, Inc.
  • 16.15. Tandem Diabetes Care, Inc.
  • 16.16. Teladoc Health, Inc.
  • 16.17. Tidepool Inc.
  • 16.18. Virta Health Corp.
  • 16.19. Wellthy Therapeutics Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD GLUCOSE METER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD GLUCOSE METER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD GLUCOSE METER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NON INVASIVE BG METER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON INVASIVE BG METER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NON INVASIVE BG METER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SMBG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SMBG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SMBG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CLOSED LOOP SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CLOSED LOOP SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CLOSED LOOP SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FULLY CLOSED LOOP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FULLY CLOSED LOOP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FULLY CLOSED LOOP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS GLUCOSE MONITOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS GLUCOSE MONITOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS GLUCOSE MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTERMITTENTLY SCANNED CGM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTERMITTENTLY SCANNED CGM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTERMITTENTLY SCANNED CGM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL REAL TIME CGM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL REAL TIME CGM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL REAL TIME CGM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INSULIN PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INSULIN PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INSULIN PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PATCH PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PATCH PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PATCH PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TUBED PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TUBED PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TUBED PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ALERT GENERATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ALERT GENERATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ALERT GENERATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DOSE RECOMMENDATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DOSE RECOMMENDATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DOSE RECOMMENDATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MACHINE LEARNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MACHINE LEARNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MACHINE LEARNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MOBILE APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MOBILE APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MOBILE APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PREDICTIVE ANALYTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PREDICTIVE ANALYTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GLUCOSE TREND PREDICTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GLUCOSE TREND PREDICTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GLUCOSE TREND PREDICTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RISK PREDICTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RISK PREDICTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RISK PREDICTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SENSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SENSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SENSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL WEARABLE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL WEARABLE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL WEARABLE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ALGORITHMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ALGORITHMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ALGORITHMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DATA MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DATA MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DATA MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL USER INTERFACE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL USER INTERFACE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL USER INTERFACE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CLOUD BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CLOUD BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CLOUD BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HYBRID CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HYBRID CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HYBRID CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PUBLIC CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PUBLIC CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PUBLIC CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ON PREMISE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ON PREMISE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ON PREMISE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL EDGE COMPUTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL EDGE COMPUTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL EDGE COMPUTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SERVER BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SERVER BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SERVER BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CLINIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CLINIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CLINIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL DIABETES CENTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL DIABETES CENTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL DIABETES CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL GENERAL CLINIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL GENERAL CLINIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL GENERAL CLINIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL REMOTE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL REMOTE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL REMOTE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL SELF MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL SELF MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL SELF MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HOSPITAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HOSPITAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL HOSPITAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL INPATIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL INPATIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL INPATIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL OUTPATIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL OUTPATIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL OUTPATIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL RESEARCH INSTITUTE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL RESEARCH INSTITUTE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL RESEARCH INSTITUTE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ACADEMIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ACADEMIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ACADEMIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL PRIVATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PRIVATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PRIVATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 266. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 287. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2032 (USD MILLION)
  • TABLE 290. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 291. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 292. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2032 (USD MILLION)
  • TABLE 293. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 295. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 296. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 297. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 298. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 299. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 300. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 301. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 302. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 304. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 305. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 306. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)

TABLE 3